EGLT Stock Recent News Egalet Corp (EGLT) 6.33 11/14/2014 21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Egalet Corp (EGLT) 6.33 $EGLT

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
EGLT: 6.33 (-0.51), VCYT: 6.77 (-0.69), ANY: 9.15 (-0.35), ALNY: 90.12 (-9.21), RTRX: 9.90 (-1.72), VASC: 23.74 (-6.76), DGLY: 11.50 (-1.72)

Egalet's (EGLT) CEO Bob Radie on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 11:18AM CST

EGLT: 6.33 (-0.51)

Egalet net loss worsens in Q3
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 9:29AM CST

EGLT: 6.33 (-0.51)

Egalet beats by $0.14
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 5:41AM CST

EGLT: 6.33 (-0.51)

Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update
PR Newswire - Wed Nov 12, 5:00AM CST
Egalet Corporation (Nasdaq: EGLT) ("Egalet" today reported business highlights and financial results for the three months ended September 30, 2014.
EGLT: 6.33 (-0.51)

Cancer Pain Therapeutics Pipeline Report 2014 - 30 Companies & 43 Drug Profiles
M2 - Thu Nov 06, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/9s5fww/cancer_pain) has announced the addition of the "Cancer Pain - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Cancer Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Pain and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Amgen Inc. - AstraZeneca PLC - BioDelivery Sciences International, Inc. - Nektar Therapeutics - Daiichi Sankyo Company, Limited - Egalet Corporation - Aphios Corporation - Nippon Kayaku Co., Ltd. - Nippon Shinyaku Co., Ltd. - Orion Oyj - Pfizer Inc. - Zeria Pharmaceutical Co Ltd - GW Pharmaceuticals plc - IntelGenx Corp. - Benitec Biopharma Limited - Kolon Life Science, Inc. - Teikoku Seiyaku Co., Ltd. - Aoxing Pharmaceutical Company, Inc - BCN Peptides, S.A. - Grunenthal GmbH - AngioChem Inc. - WEX Pharmaceuticals Inc. - Virobay Inc. - Dimerix Bioscience Pty Ltd - Winston Pharmaceuticals, Inc. - Encore Therapeutics Inc. - Sorrento Therapeutics, Inc. - Afferent Pharmaceuticals, Inc. - ChironWells GmbH - Northern Light Pharmaceuticals AB For more information visit http://www.researchandmarkets.com/research/9s...ancer_pain
BDSI: 14.47 (-0.86), PFE: 30.34 (-0.08), AMGN: 157.68 (-3.17), AXN: 0.23 (-0.02), SRNE: 4.23 (+0.02), NKTR: 13.63 (-0.23), EGLT: 6.33 (-0.51), AZN: 72.85 (-1.68), VBAY: ()

Egalet to Present at the Stifel 2014 Healthcare Conference on November 18
GlobeNewswire - Wed Nov 05, 7:30AM CST
Egalet Corporation (Nasdaq:EGLT) ("Egalet" today announced that Bob Radie, president and chief executive officer, is scheduled to present at the Stifel 2014 Healthcare Conference on Tuesday, November 18, 2014 at 4:10 p.m. EST. The conference will be held at the New York Palace Hotel.
EGLT: 6.33 (-0.51)

Egalet to Host Conference Call and Webcast to Discuss Third Quarter Financial Results on November 12, 2014
PR Newswire - Wed Oct 29, 7:30AM CDT
Egalet Corporation (Nasdaq: EGLT) ("Egalet" today announced that its third quarter financial results will be released on Wednesday, November 12, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 am Eastern Time to review the Company's financial and operating results and provide a general business update.
EGLT: 6.33 (-0.51)

FDA clears Pfizer's abuse deterrent pain med
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 4:20PM CDT

MNK: 88.11 (+1.15), EGLT: 6.33 (-0.51), ZGNX: 1.27 (+0.02), PFE: 30.34 (-0.08), TEVA: 57.07 (-0.10), ABBV: 64.00 (+0.37), ALKS: 51.47 (-1.75), ACUR: 0.51 (-0.05)

2 Oversold Stocks Under $10 Ready to Bounce Higher
at The Street - Fri Oct 17, 8:05AM CDT
Oversold can always get more oversold, but it's also an area from which a stock can experience a powerful bounce higher.
AMKR: 6.39 (unch), EGLT: 6.33 (-0.51)

Egalet (EGLT) Shows Strength: Stock Moves 7.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 8:46AM CDT
Egalet (EGLT) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.88 (-1.40), EGLT: 6.33 (-0.51), SHPG: 202.62 (+0.20), CEMP: 13.60 (-0.56)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 6

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 4

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 10

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 14

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit

Updated Category News Views 8

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 5

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 4

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 6

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
Veteran Team Fuels Misunderstood Brands' Bold Expansion

Updated Category News Views 3

Adding Heavyweights to Catalyze Growth Imagine you're Misunderstood Brands, prepping your artillery before charging into the battleground of national chains. What do you do? You double down strategically by rallying the best industry minds around. Announced on October 15, 2026, this company's concocted a dream team of beverage veterans as they steer their products—like...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 11

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading

Top 5 Most Recently Viewed Articles

Globavend Holdings Faces Major Share Price Decline Post Split

Updated Category News Views 322

Significant Decline in Globavend Holdings Shares Shares of Globavend Holdings Limited (NASDAQ: GVH) are experiencing a substantial downturn as investors react to the recent announcement of a 1-for-200 reverse stock split. This financial maneuver aims to consolidate outstanding shares, however, it is being interpreted by many as a signal of potential financial instability....

Continue Reading
Motto Mortgage Expands Reach with New Franchise Office

Updated Category News Views 329

Motto Mortgage Expands with New Franchise Office Motto Mortgage, a pioneering name in the mortgage brokerage sector, has added a new franchise to its growing network. This new office is meticulously led by a dedicated team of experienced professionals, aiming to provide homebuyers and those seeking refinancing solutions with competitive rates and profound knowledge about...

Continue Reading
Village Farms International Set to Shine at Cannabis Conference

Updated Category News Views 150

Panel Discussions That Pack a Punch The company’s heavy hitters aren’t just attending—they’re taking center stage. Michael DeGiglio, President and CEO, will grace a panel titled Europe, Australia, Southeast Asia…Canada? Where is the Real Cash Cow. Scheduled for 3 PM on October 8, this discussion aims to dissect global markets for cannabis while hunting for those...

Continue Reading
Profound Medical Corp. Unveils Key Financial Insights Soon

Updated Category News Views 92

Profound Medical Set to Release Third Quarter Financial Results Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a leading medical device company specializing in innovative, incision-free therapies for treating disease, is gearing up to deliver its financial results for the third quarter of 2024. Investors and stakeholders will be eagerly awaiting the insights that come...

Continue Reading
Steelcase's Third Quarter Update: Strong Revenue Growth Insights

Updated Category News Views 100

Steelcase Inc. Reports Third Quarter Earnings Steelcase Inc. recently announced its earnings for the third quarter of fiscal year 2025, revealing significant growth metrics and updates on future prospects. The company reported revenue of $794.9 million, which reflects a 2% increase compared to the same quarter last year when it earned $777.9 million. This revenue growth...

Continue Reading